Research Article
A Multicenter, Randomized, Open-Label Study to Compare the Effects of Gemigliptin Add-on or Escalation of Metformin Dose on Glycemic Control and Safety in Patients with Inadequately Controlled Type 2 Diabetes Mellitus Treated with Metformin and SGLT-2 Inhibitors (SO GOOD Study)
Table 3
Adverse events.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Values are presented as number (%). aAST or ALT 3 times higher than the upper limit of the normal range. b mg/dL. cWhite blood cell . AST: aspartate aminotransferase; ALT: alanine aminotransferase. |